Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
381.00    8.00 (2.14%)
Bid:
379.00
Ask:
400.00
Spread: 21.00 (5.541%)
Market Cap: £152.30m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Director/PDMR Shareholding

27 Mar 2017 10:26

RNS Number : 6076A
Dialight PLC
27 March 2017
 

Dialight plc ("Company")

 

Director/PDMR Shareholdings

27 March 2017

 

Options and Awards under the Dialight plc 2014 Performance Share Plan ("PSP")

 

On 24 March 2017 the under-mentioned Director/Person Discharging Managerial Responsibility, was granted a nil cost option which entitled her to receive ordinary shares of 1.89 pence each in the Company in accordance with the rules of the PSP.

 

Name

Number of Options granted under the PSP

Total number of shares over which incentive awards in the PSP held following notification

% of issued class

Fariyal Khanbabi (Director)

26,588

108,153

0.333

 

On 24 March 2017 the under-mentioned Director/Persons Discharging Managerial Responsibility, were granted a conditional award, which entitled them to acquire ordinary shares of 1.89 pence each in the Company in accordance with the rules of the PSP.

 

Name

Number of shares awarded under the PSP

Total number of shares over which incentive awards in the PSP held following notification

% of issued class

Michael Sutsko

(Director)

58,930

227,059

0.698

Rizwan Ahmad

4,092

15,201

0.047

Dennis Geary

3,973

10,673

0.033

John Peck

4,092

15,201

0.047

Michael Schratz

4,469

15,974

0.049

Matt Boudiette

2,979

8,004

0.025

 

Options and awards will normally vest on the third anniversary of grant subject to continued employment. In relation to the awards made to Michael Sutsko and Fariyal Khanbabi only, the award and option (respectively) are subject to the satisfaction of two performance conditions as set out below.

25% of the option or award is measured against the Company's total shareholder return ("TSR") over the three year period relative to the FTSE SmallCap Index (excluding investment trusts) ("TSR Performance Condition"), and 75% of the option or award is measured against the Company's underlying earnings per share ("EPS") in 2019 ("EPS Performance Condition").

TSR Performance Condition

No part of an option or award subject to the TSR Performance Condition shall vest if the percentage increase in the Company's TSR is below the percentage increase in the TSR of the comparator index. 25% of the ordinary shares subject to the TSR Performance Condition will vest if the percentage increase in the Company's TSR is equal to the percentage increase in the TSR of the comparator index, rising on a straight-line basis to 100% vesting if the percentage increase in the Company's TSR is equal to the increase in the TSR of the index plus 10% per annum.

EPS Performance Condition

No part of an option or award subject to the EPS Performance Condition will vest if the Company's 2019 EPS is below 62p, 25% of the ordinary shares subject to the EPS Option/Award will vest if the Company's 2019 EPS exceeds 62p, rising on a straight-line basis to 100% vesting if the Company's 2019 EPS exceeds 78p.

No consideration was paid for the grant of these options and awards and no consideration is due to be paid by the participant on the vesting of these options and awards. On vesting, options will be exercisable between 24 March 2020 and 24 March 2022.

 

Holding Period

A mandatory two-year post-vesting holding period applies to the PSP options/awards granted to Fariyal Khanbabi and Michael Sutsko.

 

 

This announcement is made in accordance with Article 19.3 of the Market Abuse Regulation.

 

Chris Fussell

General Counsel and Company Secretary

Tel: +44 (0) 20 3058 3546

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGUWPWUPMUBM
Date   Source Headline
2nd Jun 20267:00 amRNSNotice of Results & Investor Presentation
28th May 20267:00 amRNSHolding(s) in Company
26th May 20267:00 amRNSHolding(s) in Company
13th May 202612:52 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights and Admission of Shares
1st Apr 20269:54 amRNSTransaction in Own Shares
30th Mar 20263:43 pmRNSDirector/PDMR Shareholding
25th Mar 20269:32 amRNSDirector/PDMR Shareholding
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
26th Feb 20266:32 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSThird Quarter Trading Update
12th Nov 20259:33 amRNSInvestor Presentation via Investor Meet Company
11th Nov 20254:55 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSFY26 Interim Results
6th Oct 20257:00 amRNSTrading Statement
30th Sep 20257:00 amRNSBlock listing Interim Review
16th Sep 20259:39 amRNSTotal Voting Rights
3rd Sep 20251:24 pmRNSHolding(s) in Company
2nd Sep 20253:34 pmRNSResult of AGM - Addendum
1st Sep 20253:21 pmRNSResult of AGM
1st Sep 20257:00 amRNSTrading Statement
14th Aug 20251:05 pmRNSHolding(s) in Company
11th Aug 202512:58 pmRNSHolding(s) in Company
1st Aug 20255:57 pmRNSHolding(s) in Company
1st Aug 20255:54 pmRNSHolding(s) in Company
1st Aug 20255:47 pmRNSHolding(s) in Company
1st Aug 20251:33 pmRNSHolding(s) in Company
14th Jul 20252:04 pmRNSNotice of AGM
14th Jul 202510:05 amRNSAnnual Financial Report
4th Jul 20257:00 amRNSDirector/PDMR Shareholding
3rd Jul 202510:18 amRNSDirector/PDMR Shareholding
24th Jun 202512:53 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
1st May 20254:04 pmRNSDirectorate Change
7th Apr 20254:50 pmRNSTotal Voting Rights
7th Apr 20254:44 pmRNSBlock listing Interim Review
31st Mar 20257:00 amRNSSanmina Final Agreement, Trading update
20th Mar 20255:49 pmRNSApplication for Block Listing
20th Mar 20257:00 amRNSDirector Declaration
19th Mar 20253:37 pmRNSDirector/PDMR Shareholding
18th Mar 20255:17 pmRNSDirector/PDMR Shareholding
14th Mar 20252:42 pmRNSHolding(s) in Company
4th Feb 20257:30 amRNSDirector Declaration
4th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSTrading Statement
10th Dec 20247:00 amRNSDirectorate Change
25th Nov 20247:00 amRNSHalf-year Report
11th Nov 20247:00 amRNSDirectorate Change
4th Nov 20242:03 pmRNSDate of half-year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.